KRAS and colorectal carcinoma: Moreover, we analyzed the expression patterns of miR-139-5p in three different cohorts of CRC patients (the TCGA, XHDD and TMA cohorts) and found similar trends: the levels of miR-139-5p were lower in KRAS-mutant tissues than in WT tissues.